These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 343509)

  • 1. Comparative natriuretic and diuretic efficacy of theophylline ethylenediamine and of bendroflumethiazide during long-term treatment with the potent diuretic bumetanide. Permutation trial tests in patients with congestive heart failure.
    Sigurd B; Olesen KH
    Acta Med Scand; 1978; 203(1-2):113-9. PubMed ID: 343509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The supra-additive natriuretic effect addition of theophylline ethylenediamine and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide.
    Sigurd B; Olesen KH
    Am Heart J; 1977 Aug; 94(2):168-74. PubMed ID: 406769
    [No Abstract]   [Full Text] [Related]  

  • 3. The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide.
    Sigurd B; Olesen KH; Wennevold A
    Am Heart J; 1975 Feb; 89(2):163-70. PubMed ID: 1090132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diuretic action of bumetanide in congestive heart failure.
    Olsen KH; Sigurd B; Hesse B; Steiness E; Leth A
    Postgrad Med J; 1975; 51 Suppl 6():54-63. PubMed ID: 1105534
    [No Abstract]   [Full Text] [Related]  

  • 5. Bumetanide in congestive heart failure.
    Kourouklis C; Christensen O; Augoustakis D
    Curr Med Res Opin; 1976; 4(6):422-31. PubMed ID: 793779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Supra-additive natriuretic effect of theophyllamine in patients with chronic congestive heart failure during long-term therapy with bumethanide].
    Sigurd B
    Ugeskr Laeger; 1973 Oct; 135(41):2218-22. PubMed ID: 4775646
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative randomized double-blind clinical trial of bumetanide and furosemide in congestive cardiac failure and other edema states.
    Sagar S; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):473-8. PubMed ID: 6389378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramuscular bumetanide and furosemide in congestive heart failure.
    Abrams J
    J Clin Pharmacol; 1981; 21(11):673-9. PubMed ID: 7338578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance.
    Verbrugge FH; Martens P; Ameloot K; Haemels V; Penders J; Dupont M; Tang WHW; Droogné W; Mullens W
    Eur J Heart Fail; 2019 Nov; 21(11):1415-1422. PubMed ID: 31074184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amiloride. A clinical study of a potassium-retaining diuretic].
    Juul J
    Ugeskr Laeger; 1969 Oct; 131(42):1785-90. PubMed ID: 4914022
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid and Highly Accurate Prediction of Poor Loop Diuretic Natriuretic Response in Patients With Heart Failure.
    Testani JM; Hanberg JS; Cheng S; Rao V; Onyebeke C; Laur O; Kula A; Chen M; Wilson FP; Darlington A; Bellumkonda L; Jacoby D; Tang WH; Parikh CR
    Circ Heart Fail; 2016 Jan; 9(1):e002370. PubMed ID: 26721915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The supra-additive natriuretic effect addition of quinethazone or bendroflumethiazide during long-term treatment with furosemide and spironolactone. Permutation trial tests in patients with congestive heart failure.
    Olesen KH; Sigurd B
    Acta Med Scand; 1971 Sep; 190(3):233-40. PubMed ID: 4941227
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of three diuretic regimens in heart failure.
    Andreasen F; Eriksen UH; Guul SJ; Nielsen LP; Bech OM; Diamant B; Kahr O; Bruun P; Hartling OJ; Hvidt S
    Eur J Clin Invest; 1993 Apr; 23(4):234-9. PubMed ID: 8500515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bumetanide, a new potent diuretic. A clinical evaluation in congestive heart failure.
    Olesen KH; Sigurd B; Steiness E; Leth A
    Acta Med Scand; 1973; 193(1-2):119-31. PubMed ID: 4574445
    [No Abstract]   [Full Text] [Related]  

  • 15. Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use.
    Ward A; Heel RC
    Drugs; 1984 Nov; 28(5):426-64. PubMed ID: 6391889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bumetanide--a new potent diuretic for oral and intravenous use].
    Johansson BW
    Lakartidningen; 1975 Sep; 72(37):3413-6. PubMed ID: 1099368
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of once-daily versus twice-daily bumetanide in heart failure.
    Hunter KR; Underwood PN
    Postgrad Med J; 1975; 51 Suppl 6():91-95. PubMed ID: 1105538
    [No Abstract]   [Full Text] [Related]  

  • 18. Bumetanide: a new diuretic. Results of clinical efficacy and safety in patients with congestive heart failure.
    Handler B; Dhingra RC; Rosen KM
    J Clin Pharmacol; 1981; 21(11):691-6. PubMed ID: 7338580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient tolerance of long-term diuretic/potassium supplement therapy.
    Singh BB; Watt DA
    Curr Med Res Opin; 1976; 4(2):117-23. PubMed ID: 1277878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination diuretic treatment in severe heart failure: a randomised controlled trial.
    Channer KS; McLean KA; Lawson-Matthew P; Richardson M
    Br Heart J; 1994 Feb; 71(2):146-50. PubMed ID: 8130022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.